project id: TCGA-CESC; case submitter id: TCGA-C5-A3HF; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.76; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.2; rna integrity number: 9.7; age at index: 24; days to birth: -9115; days to death: 543; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1972; year of death: 1997; age at diagnosis: 9115; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8482/3; primary diagnosis: Mucinous adenocarcinoma, endocervical type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 1996; alcohol history: Not Reported; cigarettes per day: 0.4931506849315068; pack years smoked: 9.0; is ffpe: false; composition: Not Reported; days to collection: 5464; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-C5-A3HF-01A-11; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 15.0; percent stromal cells: 0.0; percent tumor cells: 80.0; percent tumor nuclei: 65.0;